Targeted Therapies for Melanoma Brain Metastases
Author:
Funder
Medical University of Vienna
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical)
Link
http://link.springer.com/content/pdf/10.1007/s11940-017-0449-2.pdf
Reference73 articles.
1. Ajithkumar T, Parkinson C, Fife K, Corrie P, Jefferies S. Evolving treatment options for melanoma brain metastases. Lancet Oncol. 2015;16(13):E486–497. doi: 10.1016/S1470-2045(15)00141-2 .
2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer. 1978;42(2):660–8.
3. Amin A, Lawson DH, Salama AK, Koon HB, Guthrie Jr T, Thomas SS, et al. Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated bBRAF-mutated metastatic melanoma. J Immunother Cancer. 2016;4:44. doi: 10.1186/S40425-016-0148-7 .
4. Atefi MS, Avramis E, Lassen A, Wong DJ, Robert L, Foulad D, et al. Effects of MAPK and PI3k pathways on PD-L1 expression in melanoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2014. doi: 10.1158/1078-0432.Ccr-13-2797 .
5. Baksh K, Weber J. Immune checkpoint protein inhibition for cancer: preclinical justification for CTLA-4 and PD-1 blockade and new combinations. Semin Oncol. 2015;42(3):363–77. doi: 10.1053/J.Seminoncol.2015.02.015 .
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PTEN-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells;British Journal of Cancer;2023-12-26
2. Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment;WIREs Mechanisms of Disease;2023-11-03
3. Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model;Clinical & Experimental Metastasis;2023-02-10
4. A 41-Year-Old Woman with a Late Cerebral Metastasis 16 Years After an Initial Diagnosis of Cutaneous Melanoma;American Journal of Case Reports;2022-02-08
5. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study;The Lancet Oncology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3